coronavirus
singlestrand
positivesens
rna
virus
subfamili
coronavirina
famili
coronavirida
caus
respiratori
gastrointestin
diseas
mammal
bird
su
et
al
coronavirus
import
pathogen
caus
emerg
reemerg
infecti
diseas
exampl
outbreak
sever
acut
respiratori
syndrom
coronaviru
sarscov
middleeast
respiratori
syndrom
coronaviru
merscov
occur
mainli
asia
respect
de
wit
et
al
felin
infecti
periton
fip
known
highli
fatal
diseas
caus
coronavirus
similar
sar
mer
dandekar
perlman
pedersen
felin
coronaviru
fcov
belong
alphacoronaviru
famili
coronavirida
de
groot
et
al
fcov
virion
mainli
compos
nucleocapsid
n
envelop
membran
peplom
spike
protein
motokawa
et
al
fcov
classifi
type
ii
accord
amino
acid
sequenc
protein
motokawa
et
al
type
ii
fcov
previous
suggest
recombin
type
fcov
type
ii
canin
coronaviru
ccov
herrewegh
et
al
terada
et
al
separ
genotypesserotyp
fcov
consist
two
biotyp
low
pathogen
felin
enter
coronaviru
fecv
lowvirul
fcov
high
pathogen
fip
viru
fipv
virul
fcov
pedersen
fipv
caus
immunemedi
inflammatori
diseas
high
mortal
domest
wild
felida
although
antivir
drug
vaccin
fip
investig
method
yet
establish
practic
use
serolog
genet
survey
reveal
type
fcov
domin
worldwid
hohdatsu
et
al
kummrow
et
al
wang
et
al
therefor
antivir
drug
vaccin
need
develop
type
fcov
infect
howev
studi
type
fcov
perform
low
replic
abil
felin
cell
line
previous
report
type
fcov
close
associ
cholesterol
throughout
viral
life
cycl
takano
et
al
also
confirm
increas
plasma
membran
cholesterol
enhanc
type
fcov
infect
find
suggest
cell
membran
cholesterol
play
import
role
type
fcov
infect
cellular
cholesterol
deriv
de
novo
cholesterol
biosynthesi
low
densiti
lipoprotein
uptak
simon
ikonen
biosynthes
entrap
cholesterol
transport
cell
heterogen
distribut
organel
associ
cholesterol
biosynthesi
transport
system
cell
viru
replic
report
aizaki
et
al
carett
et
al
mackenzi
et
al
zheng
et
al
recent
studi
shown
intracellular
cholesterol
synthesi
transport
inhibitor
potent
reduc
viral
replic
exampl
human
hepat
viru
c
hcv
rna
replic
disrupt
hmgcoa
reductas
inhibitor
honda
matsuzaki
cholesterol
transport
inhibitor
inhibit
replic
ebola
viru
carett
et
al
howev
remain
unclear
whether
cholesterol
biosynthesi
intracellular
transport
inhibitor
suppress
type
fcov
replic
cation
amphiphil
drug
cad
impair
cholesterol
biosynthesi
intracellular
transport
cenedella
inhibit
intracellular
cholesterol
biosynthesi
suppress
oxidosqualen
cyclas
cenedella
et
al
also
inhibit
cholesterol
releas
lysosom
impair
function
cholesterol
transport
niemannpick
type
ko
et
al
report
suppress
replic
ebola
viru
dengu
viru
human
hepat
c
viru
elgner
et
al
lu
et
al
poh
et
al
howev
studi
influenc
fcov
infect
report
studi
investig
whether
inhibit
fcov
infect
feli
catu
whole
fetu
fcwf
cell
kindli
suppli
dr
c
horzinek
universiteit
utrecht
grown
eagl
mem
contain
medium
fetal
calf
serum
fc
uml
penicillin
mgml
streptomycin
type
fcov
strain
fcovi
isol
laboratori
type
fcov
black
strain
fcovi
black
type
fcov
strain
fcovi
type
fcov
strain
fcovi
kindli
suppli
dr
j
k
yamamoto
univers
florida
type
ii
fcov
wsu
strain
fcovii
kindli
provid
dr
c
horzinek
universiteit
utrecht
type
ii
fcov
wsu
fcovii
kindli
provid
dr
j
mckeirnan
washington
state
univers
type
ii
ccov
strain
ccovii
suppli
dr
e
takahashi
univers
tokyo
virus
grown
cell
c
methylbcyclodextrin
mbcd
ro
amorolfin
simvastatin
clomiphen
alendron
purchas
sigma
aldrich
usa
lovastatin
fluvastatin
itraconazol
purchas
wako
pure
chemic
japan
vorinostat
purchas
cayman
chemic
usa
mbcd
dissolv
water
mm
mbcd
stock
respect
compound
dissolv
dimethyl
sulfoxid
dmso
mm
stock
day
experi
compound
dilut
desir
concentr
mainten
medium
cell
seed
plate
compound
ad
triplic
well
incub
defin
period
cultur
supernat
remov
solut
kishida
chemic
japan
ad
cell
return
incub
h
absorb
formazan
produc
measur
nm
spectrophotometr
plate
reader
describ
manufactur
percentag
viabil
calcul
use
follow
formula
cytotox
od
compounduntr
cell
compoundtr
cell
od
compounduntr
cell
cellular
cholesterol
content
cell
evalu
cholesterol
cell
base
detect
assay
kit
cayman
chemic
usa
accord
manufactur
instruct
briefli
cell
grown
labtek
chamber
slide
thermo
fisher
scientif
usa
semiconflu
cell
monolay
cultur
medium
contain
mm
c
h
fix
stain
filipin
iiibind
cell
analyz
use
leica
microscop
la
x
integr
imag
system
leica
microsystem
germani
amount
intracellular
cholesterol
determin
use
amplex
red
cholesterol
assay
kit
molecular
probe
usa
follow
manufactur
instruct
confluent
cell
monolay
cultur
medium
contain
compound
indic
concentr
multipl
c
h
cell
wash
viru
moi
adsorb
cell
c
h
wash
cell
cultur
carboxymethyl
cellulos
cmc
mem
mem
case
cell
cultur
cmcmem
cell
monolay
incub
c
h
fix
stain
crystal
violet
solut
contain
buffer
formalin
result
plaqu
count
percentag
plaqu
decreas
increas
determin
use
follow
formula
percentag
plaqu
reduct
plaqu
number
cell
plaqu
number
cell
case
cell
cultur
mem
cultur
supernat
collect
h
postinfect
viru
titer
determin
tcid
assay
cell
grown
labtek
chamber
slide
thermo
fisher
scientif
usa
semiconflu
cell
monolay
cultur
medium
contain
mm
c
h
cell
wash
viru
moi
adsorb
cell
c
h
wash
cell
cultur
mem
cell
monolay
incub
c
h
n
protein
level
determin
immunofluoresc
assay
ifa
describ
previous
hohdatsu
et
al
recogn
fcov
n
protein
mab
mous
prepar
laboratori
use
hohdatsu
et
al
confluent
cell
cultur
medium
contain
mm
h
wash
viru
moi
adsorb
cell
c
h
cell
wash
cultur
cmcmem
cell
monolay
incub
c
h
fix
stain
result
plaqu
count
percentag
plaqu
reduct
measur
refer
method
describ
confluent
cell
monolay
cultur
medium
contain
mm
multipl
c
h
wash
cell
cultur
medium
contain
vorinostat
indic
concentr
h
cell
wash
viru
moi
adsorb
cell
c
h
cell
wash
cultur
cmcmem
cell
monolay
incub
c
h
postinocul
fix
stain
result
plaqu
count
percentag
plaqu
reduct
measur
refer
method
describ
influenc
vorinostat
intracellular
distribut
cholesterol
investig
describ
influenc
viru
infect
vorinostattr
cell
confirm
ifa
describ
data
two
group
analyz
student
ttest
welch
ttest
bartlett
test
multipl
group
analyz
oneway
anova
follow
tukey
test
cytotox
assay
perform
determin
nontox
concentr
cell
fig
cytotox
concentr
cc
cytotox
concentr
cc
valu
mean
se
mm
mean
se
mm
respect
investig
chang
cellular
cholesterol
content
cell
caus
accumul
cholesterol
measur
filipin
iii
stain
fig
determin
whether
affect
cellular
cholesterol
content
level
cholesterol
cell
measur
although
level
cellular
cholesterol
significantli
decreas
mm
mbcdtreat
cell
neither
mm
mm
decreas
cellular
cholesterol
level
fig
order
confirm
effect
accumul
cholesterol
fcov
infect
cell
pretreat
follow
viru
inocul
pretreat
demonstr
reduct
fcovi
plaqu
format
fig
e
contrast
percentag
plaqu
reduct
fcovii
affect
pretreat
investig
express
viral
protein
order
determin
effect
fcov
infect
n
protein
level
fcovi
specif
decreas
cell
pretreat
fig
contrast
fcovi
pretreat
affect
n
protein
level
fcovii
cell
relationship
fcov
serotyp
antivir
effect
investig
influenc
replic
strain
type
fcov
fcovi
fcovi
black
fcovi
fcovi
strain
type
ii
fcov
fcovii
fcovii
strain
type
ii
ccov
ccovii
cell
investig
pretreat
reduc
type
fcov
plaqu
format
dosedepend
manner
fig
contrast
percentag
plaqu
reduct
type
ii
fcov
type
ii
ccov
slightli
affect
pretreat
fig
viru
titer
type
fcov
significantli
decreas
cultur
supernat
cell
pretreat
mm
higher
fig
product
fcovi
fcovi
fcovi
cultur
supernat
complet
inhibit
cell
pretreat
mm
contrast
type
fcov
pretreat
affect
titer
type
ii
fcov
type
ii
ccov
supernat
cell
fig
pretreat
experi
perform
determin
period
exert
antivir
effect
pretreat
significantli
increas
degre
reduct
fcovi
plaqu
format
h
prior
infect
fig
cholesterol
accumul
observ
cell
reaction
time
fig
cholesterol
accumul
note
cell
pretreat
h
cholesterol
accumul
mostli
lost
cell
pretreat
h
complet
disappear
cell
pretreat
h
inhibit
fcov
infect
compound
biochem
properti
similar
investig
pretreat
cad
except
amorolfin
significantli
increas
degre
reduct
fcovi
plaqu
format
fig
cell
pretreat
cholesterol
biosynthesi
inhibitor
itraconazol
significantli
inhibit
fcovi
plaqu
format
cholesterol
biosynthesi
inhibitor
show
signific
inhibitori
effect
fcovi
plaqu
format
drug
exhibit
signific
inhibitori
effect
type
ii
fcov
plaqu
format
select
index
si
calcul
cc
half
maxim
effect
concentr
ec
drug
type
fcov
si
valu
clomiphen
ro
itraconazol
high
tabl
contrast
type
ii
fcov
si
valu
drug
low
clomiphen
ro
itraconazol
significantli
inhibit
fcovi
plaqu
format
inhibit
function
cholesterol
transport
unlik
drug
amorolfin
fluvastatin
lovastatin
simvastatin
alendron
base
assum
inhibit
type
fcov
replic
associ
reduct
function
investig
whether
hdaci
improv
reduc
function
resolv
cholesterol
accumul
inhibit
type
fcov
replic
hdaci
vorinostat
ad
cell
cholesterol
accumul
reduc
fig
influenc
vorinostat
fcovi
replic
investig
use
plaqu
reduct
assay
vorinostat
ad
cell
percentag
plaqu
reduct
significantli
decreas
fig
c
influenc
vorinostat
n
protein
express
level
fcovinfect
cell
investig
use
fluoresc
antibodi
method
n
protein
level
fcovi
specif
decreas
cell
pretreat
hand
addit
vorinostat
cell
increas
level
fcovi
n
protein
fig
sever
studi
made
role
cholesterol
coronaviru
infect
thorp
gallagh
nomura
et
al
ren
et
al
howev
influenc
intracellular
synthesi
transport
system
cholesterol
investig
suppress
cholesterol
biosynthesi
function
cholesterol
transport
studi
investig
antifcov
activ
induc
intracellular
cholesterol
accumul
strongli
inhibit
type
fcov
replic
addit
treatment
cell
influenc
cellular
cholesterol
level
suggest
inhibit
type
fcov
replic
concentr
suppress
cholesterol
transport
influenc
synthesi
system
contrast
type
fcov
inhibitori
effect
type
ii
fcov
replic
note
previous
report
type
fcov
infect
depend
plasma
membran
cholesterol
type
ii
fcov
takano
et
al
find
present
previou
studi
suggest
type
fcov
requir
cholesterol
infect
cell
type
ii
fcov
requir
cholesterol
infect
suggest
type
ii
fcov
arisen
doubl
recombin
type
fcov
type
ii
ccov
herrewegh
et
al
terada
et
al
fcovii
genom
region
encod
protein
deriv
type
ii
ccov
region
deriv
type
fcov
herrewegh
et
al
suggest
gene
factor
lead
differ
virolog
properti
fcov
serotyp
gene
homolog
gene
sequenc
serotyp
low
similar
motokawa
et
al
suggest
involv
differ
effect
type
ii
fcov
protein
encod
import
protein
bind
viru
receptor
cell
entri
gallagh
buchmeier
physic
properti
protein
markedli
differ
type
ii
fcov
exampl
type
ii
fcov
protein
bind
viru
receptor
aminopeptidas
n
apn
type
fcov
protein
bind
apn
hohdatsu
et
al
addit
type
fcov
protein
bind
heparin
type
ii
fcov
protein
de
haan
et
al
differ
protein
properti
serotyp
may
also
influenc
differ
effect
demonstr
assumpt
necessari
prepar
recombin
fcov
contain
type
fcov
gene
replac
type
ii
fcov
gene
confirm
influenc
replic
recombin
fcov
expect
studi
inhibit
type
ii
fcov
type
ii
ccov
product
contrari
previous
report
mbcd
cholesterol
extract
agent
inhibit
type
ii
ccov
type
ii
fcov
pratelli
colao
takano
et
al
mbcd
disrupt
cholesteroland
caveolinrich
membran
domain
caveola
dalessio
et
al
van
hamm
et
al
report
type
ii
fcov
shown
enter
cell
caveolaeindepend
endocytosi
basi
report
suggest
type
ii
ccov
enter
cell
via
caveola
addit
h
viral
infect
significantli
inhibit
type
fcov
replic
durat
exposur
requir
inhibit
type
fcov
replic
mostli
consist
requir
cholesterol
accumul
cell
strongli
suggest
cholesterol
transport
inhibit
type
fcov
replic
also
inhibit
hcv
replic
inhibit
report
replic
virion
releas
endosom
hcvreplic
cell
treat
h
ie
hcv
virion
accumul
cholesterol
late
endosom
elgner
et
al
probabl
type
fcov
replic
also
inhibit
accumul
late
endosom
inhibitor
cholesterol
transport
ko
et
al
bind
block
function
lu
et
al
studi
clomiphen
ro
itraconazol
block
function
similarli
shoemak
et
al
trinh
et
al
also
exhibit
type
fcov
replicationinhibitori
effect
suggest
type
fcov
replic
inhibit
block
function
verifi
hypothesi
investig
influenc
hdaci
type
fcov
replicationinhibitori
effect
contrast
hdaci
revert
dysfunct
pipalia
et
al
vorinostat
ad
cell
intracellular
cholesterol
accumul
disappear
type
fcov
replic
resum
knowledg
revers
inhibit
viru
replic
hdaci
previous
report
necessari
determin
whether
phenomenon
observ
ebolaviru
dengu
viru
hcv
suggest
breed
cat
influenc
suscept
fip
pesteanusomogyi
et
al
report
incid
fip
among
breed
cat
show
incid
fip
lowest
siames
cat
interestingli
siames
cat
breed
seem
genet
predisposit
npc
diseas
wenger
et
al
dysfunct
caus
npc
diseas
fact
find
studi
suggest
impair
function
caus
low
incid
fip
siames
cat
say
cat
may
less
sensit
type
fcov
domin
serotyp
field
hohdatsu
et
al
kummrow
et
al
wang
et
al
investig
type
fcov
sensit
siames
cat
necessari
strongli
inhibit
type
fcov
replic
inhibit
type
ii
fcov
replic
suggest
inhibit
type
fcov
replic
suppress
intracellular
cholesterol
transport
experi
use
hdaci
suggest
dysfunct
involv
antivir
effect
type
fcov
wide
present
field
may
appli
therapeut
drug
fip
necessari
investig
whether
administr
exhibit
therapeut
effect
cat
fip
determin
caus
revers
inhibit
viru
replic
hdaci
